VOYA Investment Management’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.4K Buy
+21,461
New +$38.4K ﹤0.01% 2462
2024
Q4
– Sell
-12,813
Closed -$23.3K – 2733
2024
Q3
$23.3K Buy
12,813
+1,598
+14% +$5.94K ﹤0.01% 2804
2024
Q2
$67.6K Buy
+11,215
New +$138K ﹤0.01% 2752
2024
Q1
– Sell
-10,708
Closed -$159K – 2786
2023
Q4
$159K Buy
+10,708
New +$102K ﹤0.01% 2642
2021
Q4
– Sell
-6,946
Closed -$513K – 2776
2021
Q3
$513K Sell
6,946
-200
-3% -$13.3K ﹤0.01% 2033
2021
Q2
$391K Sell
7,146
-453
-6% -$27.1K ﹤0.01% 2235
2021
Q1
$560K Buy
7,599
+3,427
+82% +$270K ﹤0.01% 1960
2020
Q4
$360K Buy
+4,172
New +$251K ﹤0.01% 2104

Other funds holding ALXO

VOYA Investment Management's ALXO Position: Q2 2026 in Review

VOYA Investment Management opened a new position in ALX Oncology (ALXO) in Q2 2026: 21,461 shares worth $44.4K. The stake represents ﹤0.01% of the portfolio and ranks #2462 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in ALXO as recently as Q3 2024.

VOYA Investment Management first reported a position in ALXO in Q4 2020 and has held it in 8 quarters since. The position peaked at $560K in Q1 2021. 93 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • VOYA Investment Management held 21,461 shares of ALX Oncology worth $44.4K as of Q2 2026.
  • ALX Oncology was a new VOYA Investment Management position in Q2 2026.
  • ALX Oncology made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2462 holding.
  • VOYA Investment Management first reported a position in ALX Oncology in Q4 2020 and has held it in 8 quarters since.
  • VOYA Investment Management's ALX Oncology position peaked at $560K in Q1 2021.
  • 93 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.